These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32031980)

  • 21. Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.
    Wihastuti TA; Heriansyah T; Hanifa H; Andarini S; Sholichah Z; Sulfia YH; Adam AA; Refialdinata J; Lutfiana NC
    Endocr Regul; 2018 Apr; 52(2):69-75. PubMed ID: 29715185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation.
    Moguillansky D; Leng X; Carson A; Lavery L; Schwartz A; Chen X; Villanueva FS
    Eur Heart J; 2011 Mar; 32(5):646-53. PubMed ID: 20581005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque.
    Drinane M; Mollmark J; Zagorchev L; Moodie K; Sun B; Hall A; Shipman S; Morganelli P; Simons M; Mulligan-Kehoe MJ
    Circ Res; 2009 Feb; 104(3):337-45. PubMed ID: 19122176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model.
    Decano JL; Moran AM; Ruiz-Opazo N; Herrera VL
    Mol Imaging Biol; 2011 Dec; 13(6):1096-106. PubMed ID: 20972637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo.
    Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculogenic properties of adventitial Sca-1
    Toledo-Flores D; Williamson A; Schwarz N; Fernando S; Dimasi C; Witt TA; Nguyen TM; Puranik AS; Chue CD; Delacroix S; Spoon DB; Bonder CS; Bursill CA; Di Bartolo BA; Nicholls SJ; Simari RD; Psaltis PJ
    Sci Rep; 2019 May; 9(1):7286. PubMed ID: 31086203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia.
    Herrmann J; Lerman LO; Rodriguez-Porcel M; Holmes DR; Richardson DM; Ritman EL; Lerman A
    Cardiovasc Res; 2001 Sep; 51(4):762-6. PubMed ID: 11530109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients.
    Sargowo D; Ovianti N; Susilowati E; Ubaidillah N; Widya Nugraha A; Vitriyaturrida ; Siwi Proboretno K; Failasufi M; Ramadhan F; Wulandari H; Waranugraha Y; Hayuning Putri D
    Indian Heart J; 2018; 70(5):608-614. PubMed ID: 30392496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
    Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
    Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A2 and YKL-40.
    Zhang H; Zhou W; Cao C; Zhang W; Liu G; Zhang J
    PLoS One; 2018; 13(8):e0202797. PubMed ID: 30138439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
    Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dynamic vasa vasorum.
    Ritman EL; Lerman A
    Cardiovasc Res; 2007 Sep; 75(4):649-58. PubMed ID: 17631284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Lp-PLA2 in lipid-lowering therapy.
    Racherla S; Arora R
    Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
    Kwon HM; Sangiorgi G; Ritman EL; McKenna C; Holmes DR; Schwartz RS; Lerman A
    J Clin Invest; 1998 Apr; 101(8):1551-6. PubMed ID: 9541483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology.
    Tian J; Hu S; Han X; Dong N; Yu H; Sun Y; Yu B
    Inflammation; 2012 Aug; 35(4):1530-7. PubMed ID: 22538510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adventitial fibroblast-derived vascular endothelial growth factor promotes vasa vasorum-associated neointima formation and macrophage recruitment.
    Li XD; Hong MN; Chen J; Lu YY; Ye MQ; Ma Y; Zhu DL; Gao PJ
    Cardiovasc Res; 2020 Mar; 116(3):708-720. PubMed ID: 31241138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lipoprotein-associated phospholipase A2 inhibitor on insulin resistance in streptozotocin-induced diabetic pregnant rats.
    Wang GH; Jin J; Sun LZ
    Endocr J; 2018 Sep; 65(9):903-913. PubMed ID: 29925744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasa vasorum and atherosclerosis - Quid novi?
    Langheinrich AC; Kampschulte M; Buch T; Bohle RM
    Thromb Haemost; 2007 Jun; 97(6):873-9. PubMed ID: 17549287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes.
    Bloor J; Shukla N; Smith FC; Angelini GD; Jeremy JY
    Diabetologia; 2010 May; 53(5):980-8. PubMed ID: 20182861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.